Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Transitional Drugs 7

NHS Wales Shared Services Partnership-Procurement Services

This public procurement record has 4 releases in its history.

Award

30 Jun 2026 at 17:12

UK7 - Contract Details Notice
Award

05 Jun 2026 at 10:08

UK6 - Contract Award Notice
Tender

10 Apr 2026 at 12:50

UK4 - Tender Notice
Planning

08 Apr 2026 at 10:44

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) has awarded a contract titled "Transitional Drugs 7" for the provision of pharmaceutical products that have recently lost exclusivity. The contract was signed on 30th June 2026 and spans from 1st July 2026 to 30th June 2028, with a provision for a further 24-month extension. The open procedure procurement process, primarily under the goods category, involved multiple large suppliers, including Amgen Ltd, Celltrion Healthcare, and Novartis Pharmaceuticals UK Ltd, targeting the UK region, specifically Wales. The procurement falls under the legal framework of the Welsh devolved regulations and the central government public authority type.

This procurement opportunity provides significant business growth potential, especially for large-scale pharmaceutical suppliers experienced in manufacturing and supplying drugs that have lost patent protection. Given the substantial contract value of over £16 million, only enterprises with robust production capabilities and compliance with regulatory standards would be considered well-suited to compete. The involvement in such a tender allows businesses to enhance their market reach within the UK's healthcare sector, reinforcing their brand presence in the supply chain for high-demand pharmaceutical commodities.

How relevant is this notice?

Notice Information

Notice Title

Transitional Drugs 7

Notice Description

The provision of Drugs that have recently lost exclusivity

Lot Information

Lot 1

Renewal: Extension option of up to 2 years available.

Planning Information

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts). There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published, please contact Jennifer Tresilian (jennifer.tresilian@wales.nhs.uk)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-067da4
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/061468-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£53,566,932 £10M-£100M
Lots Value
£53,566,932 £10M-£100M
Awards Value
£16,804,001 £10M-£100M
Contracts Value
£16,804,001 £10M-£100M

Notice Dates

Publication Date
30 Jun 20263 months ago
Submission Deadline
Not specified
Future Notice Date
10 Apr 2026Expired
Award Date
4 Jun 20264 months ago
Contract Period
1 Jul 2026 - 30 Jun 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS Wales Shared Services Partnership-Procurement Services
Additional Buyers

NHS Wales Shared Services Partnership - Procurement Services (hosted by Velindre NHS Trust)

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 3UZ
Postcode Area
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL Wales
Local Authority
Cardiff
Electoral Ward
Gabalfa
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
10
Supplier Names

Amgen Ltd

Fresenius Kabi Limited

Celltrion Healthcare United Kingdom Limited

Hikma Pharmaceuticals

Vifor Pharma UK Ltd

Roche Products Ltd

Gedeon Richter UK Ltd

Novartis Pharmaceuticals UK Ltd

Mercury Pharmaceuticals Limited

Celix Pharma Ltd.

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...